The overexpressed C3 in blood and downregulated C3 in tumor tissues were observed in lung cancer patients, and related to poorer prognosis (Ajona et al., 2013; Lin et al., 2014; Mehan et al., 2012). Here, C3 is linked to lung carcinoma.